0000882104-16-000100.txt : 20160128
0000882104-16-000100.hdr.sgml : 20160128
20160128185418
ACCESSION NUMBER: 0000882104-16-000100
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160126
FILED AS OF DATE: 20160128
DATE AS OF CHANGE: 20160128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PDL BIOPHARMA, INC.
CENTRAL INDEX KEY: 0000882104
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 943023969
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
BUSINESS PHONE: 775-832-8500
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
FORMER COMPANY:
FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE
DATE OF NAME CHANGE: 19930328
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Pietzke Steffen
CENTRAL INDEX KEY: 0001647008
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19756
FILM NUMBER: 161370553
MAIL ADDRESS:
STREET 1: 932 SOUTHWOOD BLVD
CITY: INCLINE VILLAGE
STATE: NV
ZIP: 89451
4
1
wf-form4_145402524596454.xml
FORM 4
X0306
4
2016-01-26
0
0000882104
PDL BIOPHARMA, INC.
PDLI
0001647008
Pietzke Steffen
932 SOUTHWOOD BLVD.
INCLINE VILLAGE
NV
89451
0
1
0
0
Controller and CAO
Common stock
2016-01-26
4
A
0
31135
3.22
A
47724
D
The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved,based upon the following schedule: 50% on December 2017; 16.66% on December 2018; 16.66% on December 2019; and 16.66% on December 2020.
/s/ Nathan N. Kryszak, Attorney-in-Fact for Steffen Pietzke
2016-01-28